mafosfamide

DRUG2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Brain and Central Nervous System TumorsLeukemiaLymphomaMeningeal Neoplasm

Phase 1

Phase I Study of Intrathecal Mafosfamide

CompletedNCT00001251

National Cancer Institute (NCI)Leukemia, Lymphoma, Meningeal Neoplasm

Start: 1989-11-30End: 2003-11-30Target: 65Updated: 2013-08-19

Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors

CompletedNCT00031928

National Cancer Institute (NCI)Brain and Central Nervous System Tumors

Start: 2002-01-31Target: 3000Updated: 2015-04-30